2015 · GS Paper 4 · Q11 · 20 marks

One of the scientists working in the R & D laboratory of a major pharmaceutical company discovers that one of the company's best selling veterinary drugs, B has the potential to cure a currently incurable liver disease that is prevalent in tribal areas. However, developing a variant of the drug suitable for human beings entailed a lot of research and development having a huge expenditure to the extent of ₹ 50 crores. It was unlikely that the company would recover the costs as the disease was rampant only in poverty-stricken area having very little market otherwise. If you were the CEO, then— (a) identify the various actions that you could take; (b) evaluate the pros and cons of each of your actions.

In short

As CEO, the best course is to develop the human variant of drug B through a cost-sharing partnership with ICMR and global health partners, then supply it at tiered prices. Merck's Mectizan Donation Program shows how a veterinary drug, ivermectin, became a free cure for river blindness.

Model answer

Ghissu Editorial · Verified 4 Oct 2026

Introduction
The dilemma is between Profitability, recovering ₹50 crore for investors, and Public Health Welfare, a cure for poor tribal patients.
(a) Actions Available to the CEO
The issues are a neglected disease the market ignores and the risk of Moral Myopia. I could shelve the finding, develop it alone and give it free, price it for profit, hand the data to ICMR, or develop it through a partnership.
(b) Pros and Cons of Each Action
•

(i) EVADE [Procedural-Evasive]

Shelving protects margins but is Bystander Apathy towards curable suffering.

•

(ii) CONFRONT [Empathetic-Humanitarian]

Free development is compassionate but strains fiduciary duty.

•

(iii) CAPITULATE [Strict-Legal]

Patent pricing is lawful and recovers costs, but excludes the very patients who need the cure.

•

(iv) COMPROMISE [Compromised-Hybrid]

Handing data to ICMR is cheap, but the cure may never reach patients.

•

(v) RECONCILE ✓ [Balanced]

Co-develop with ICMR and a partner like DNDi [current event], then supply at tiered prices (recommended).

Justification:
Gandhi's Talisman: recalling the poorest tribal patient makes the partnership route right, as it cures without ruining the firm.
Conclusion
Profit and welfare are a false binary; as CEO I would develop the cure through partnership, acting as a trustee of both investors and society, so the cure reaches the tribal patients who need it most.

This model answer is indicative and the model can make mistakes; please verify key facts independently.

Hand-drawn diagram: Profitability vs Public Health Welfare. Profitability vs Public Health Welfare. Venn diagram: Profitability, Public Health Welfare; overlap: Partnership-funded, affordable cure
Diagram: Profitability vs Public Health Welfare

Practise this question

  1. 1Get the answer sheet

    Sized for this question.

  2. 2Write your answer

    Timed, by hand.

  3. 3Get it marked

    Your score and what to fix.

Share this questionWhatsAppTelegramXLinkedIn

This chapter in the exam

Corporate Conduct8 questions

Asked in 7 of 14 sittings since 2013

2013
–
2014
1
2015
2
2016
1
2017
–
2018
–
2019
–
2020
1
2021
1
2022
1
2023
–
2024
1
2025
–
2026
–

All 8 questions, sorted by sub-topic, with model answers and practice.

Question from the official UPSC Civil Services (Main) Examination 2015 paper. Answer written by Ghissu's engine and checked against our editorial standards. Found an error? Tell us and we correct it within 48 hours.

Ghissu

OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·